Cite
MO1-15-3 Efficacy of Radiotherapy to Primary Tumor After Nivolumab Treatment in Patients with Advanced Gastric Cancer.
MLA
Sasaki, Akinori, et al. “MO1-15-3 Efficacy of Radiotherapy to Primary Tumor After Nivolumab Treatment in Patients with Advanced Gastric Cancer.” Annals of Oncology, vol. 30, Oct. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1093/annonc/mdz338.027.
APA
Sasaki, A., Nakamura, Y., Kuno, H., Togashi, Y., Hojo, H., Nakamura, N., Takashima, K., Kadota, T., Mishima, S., Kotani, D., Kawazoe, A., Kuboki, Y., Taniguti, H., Doi, T., Yoshino, T., Kobayashi, T., Nishikawa, H., Akimoto, T., Yano, T., & Shitara, K. (2019). MO1-15-3 Efficacy of Radiotherapy to Primary Tumor After Nivolumab Treatment in Patients with Advanced Gastric Cancer. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz338.027
Chicago
Sasaki, Akinori, Yoshiaki Nakamura, Hirofumi Kuno, Yosuke Togashi, Hidehiro Hojo, Naoki Nakamura, Kenji Takashima, et al. 2019. “MO1-15-3 Efficacy of Radiotherapy to Primary Tumor After Nivolumab Treatment in Patients with Advanced Gastric Cancer.” Annals of Oncology 30 (October): N.PAG. doi:10.1093/annonc/mdz338.027.